Identification of new candidate biomarkers to support doxorubicin treatments in canine cancer patients

BACKGROUND: Both human and veterinary cancer chemotherapy are undergoing a paradigm shift from a “one size fits all” approach to more personalized, patient-oriented treatment strategies. Personalized chemotherapy is dependent on the identification and validation of biomarkers that can predict treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Walters, Kristine, Stornetta, Alessia, Jacobs, Foster, Villalta, Peter W., Razzoli, Maria, Grant, Marianne, Zordoky, Beshay, Bartolomucci, Alessandro, Borgatti, Antonella, Balbo, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650425/
https://www.ncbi.nlm.nih.gov/pubmed/34876121
http://dx.doi.org/10.1186/s12917-021-03062-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650425/
https://www.ncbi.nlm.nih.gov/pubmed/34876121
http://dx.doi.org/10.1186/s12917-021-03062-x

Ejemplares similares